

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | imidazole-containing compound metabolic process (GO:0052803) | 8.89312164 |
| 2 | leukocyte migration involved in inflammatory response (GO:0002523) | 8.64012677 |
| 3 | defense response to fungus (GO:0050832) | 8.51045889 |
| 4 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 8.44957188 |
| 5 | leukocyte aggregation (GO:0070486) | 8.43687718 |
| 6 | superoxide anion generation (GO:0042554) | 8.27198261 |
| 7 | innate immune response in mucosa (GO:0002227) | 8.13408670 |
| 8 | antibacterial humoral response (GO:0019731) | 8.11486506 |
| 9 | antimicrobial humoral response (GO:0019730) | 7.46000059 |
| 10 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 7.21234468 |
| 11 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 7.21234468 |
| 12 | response to fungus (GO:0009620) | 7.20000663 |
| 13 | neutrophil activation (GO:0042119) | 6.93307434 |
| 14 | mucosal immune response (GO:0002385) | 6.91251243 |
| 15 | sequestering of metal ion (GO:0051238) | 6.72926105 |
| 16 | respiratory burst (GO:0045730) | 6.58099777 |
| 17 | * negative regulation of interleukin-10 production (GO:0032693) | 6.53781220 |
| 18 | organ or tissue specific immune response (GO:0002251) | 6.49022992 |
| 19 | granulocyte activation (GO:0036230) | 6.47208710 |
| 20 | leukotriene metabolic process (GO:0006691) | 6.26874744 |
| 21 | response to peptidoglycan (GO:0032494) | 6.15133703 |
| 22 | leukotriene biosynthetic process (GO:0019370) | 5.92756464 |
| 23 | protoporphyrinogen IX metabolic process (GO:0046501) | 5.86989422 |
| 24 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 5.75622453 |
| 25 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 5.67531493 |
| 26 | oxygen transport (GO:0015671) | 5.64969091 |
| 27 | reactive oxygen species biosynthetic process (GO:1903409) | 5.62645623 |
| 28 | negative regulation of interleukin-8 production (GO:0032717) | 5.52090919 |
| 29 | neutrophil mediated immunity (GO:0002446) | 5.47229011 |
| 30 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 5.46788054 |
| 31 | killing of cells of other organism (GO:0031640) | 5.38755205 |
| 32 | disruption of cells of other organism (GO:0044364) | 5.38755205 |
| 33 | hydrogen peroxide biosynthetic process (GO:0050665) | 5.37083635 |
| 34 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.35390525 |
| 35 | negative regulation of cell killing (GO:0031342) | 5.35390525 |
| 36 | detection of other organism (GO:0098543) | 5.18799686 |
| 37 | chronic inflammatory response (GO:0002544) | 5.15786524 |
| 38 | regulation of female gonad development (GO:2000194) | 5.15492140 |
| 39 | gas transport (GO:0015669) | 4.77907634 |
| 40 | * positive regulation of interleukin-4 production (GO:0032753) | 4.77061944 |
| 41 | macrophage differentiation (GO:0030225) | 4.58607635 |
| 42 | negative regulation of phagocytosis (GO:0050765) | 4.56654393 |
| 43 | neutrophil activation involved in immune response (GO:0002283) | 4.55224169 |
| 44 | regulation of lipoprotein particle clearance (GO:0010984) | 4.51787696 |
| 45 | cellular extravasation (GO:0045123) | 4.40180483 |
| 46 | hemoglobin metabolic process (GO:0020027) | 4.38848444 |
| 47 | defense response to Gram-positive bacterium (GO:0050830) | 4.34144346 |
| 48 | myeloid dendritic cell differentiation (GO:0043011) | 4.28412794 |
| 49 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.25110095 |
| 50 | regulation of T-helper 1 cell differentiation (GO:0045625) | 4.22928551 |
| 51 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 4.19972175 |
| 52 | myeloid leukocyte mediated immunity (GO:0002444) | 4.12832252 |
| 53 | positive regulation of antigen processing and presentation (GO:0002579) | 4.10479297 |
| 54 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.06568095 |
| 55 | negative regulation of interleukin-12 production (GO:0032695) | 4.03966591 |
| 56 | regulation of leukocyte degranulation (GO:0043300) | 4.02494830 |
| 57 | dendritic cell differentiation (GO:0097028) | 4.01389663 |
| 58 | intracellular estrogen receptor signaling pathway (GO:0030520) | 3.99278438 |
| 59 | positive regulation of B cell differentiation (GO:0045579) | 3.97702769 |
| 60 | peptide catabolic process (GO:0043171) | 3.93233953 |
| 61 | erythrocyte maturation (GO:0043249) | 3.91986557 |
| 62 | neutrophil chemotaxis (GO:0030593) | 3.86344711 |
| 63 | dendritic cell chemotaxis (GO:0002407) | 3.85062406 |
| 64 | mannose metabolic process (GO:0006013) | 3.84250791 |
| 65 | positive regulation of steroid hormone secretion (GO:2000833) | 3.82933729 |
| 66 | positive regulation of granulocyte differentiation (GO:0030854) | 3.81787610 |
| 67 | negative regulation of interleukin-6 production (GO:0032715) | 3.79396387 |
| 68 | pentose-phosphate shunt (GO:0006098) | 3.76531290 |
| 69 | neutrophil migration (GO:1990266) | 3.75402395 |
| 70 | porphyrin-containing compound biosynthetic process (GO:0006779) | 3.73999725 |
| 71 | myeloid dendritic cell activation (GO:0001773) | 3.73721118 |
| 72 | definitive hemopoiesis (GO:0060216) | 3.73595569 |
| 73 | superoxide metabolic process (GO:0006801) | 3.72864207 |
| 74 | myeloid cell development (GO:0061515) | 3.70469315 |
| 75 | defense response to bacterium (GO:0042742) | 3.65389831 |
| 76 | leukocyte mediated cytotoxicity (GO:0001909) | 3.62943913 |
| 77 | erythrocyte development (GO:0048821) | 3.59538612 |
| 78 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 3.59487209 |
| 79 | regulation of mast cell degranulation (GO:0043304) | 3.55141540 |
| 80 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.54835552 |
| 81 | positive regulation of mast cell degranulation (GO:0043306) | 3.54835552 |
| 82 | regulation of regulated secretory pathway (GO:1903305) | 3.54554155 |
| 83 | leukocyte cell-cell adhesion (GO:0007159) | 3.49510456 |
| 84 | regulation of interleukin-8 production (GO:0032677) | 3.48770630 |
| 85 | regulation of antigen processing and presentation (GO:0002577) | 3.44564130 |
| 86 | positive regulation of mast cell activation (GO:0033005) | 3.44464904 |
| 87 | regulation of tolerance induction (GO:0002643) | 3.44062875 |
| 88 | response to host immune response (GO:0052572) | 3.42079694 |
| 89 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.42079694 |
| 90 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.40697682 |
| 91 | megakaryocyte development (GO:0035855) | 3.39216463 |
| 92 | detection of external biotic stimulus (GO:0098581) | 3.38605738 |
| 93 | positive regulation of T-helper 1 type immune response (GO:0002827) | 3.38111711 |
| 94 | response to methylmercury (GO:0051597) | 3.38008842 |
| 95 | NADPH regeneration (GO:0006740) | 3.34406032 |
| 96 | cellular biogenic amine biosynthetic process (GO:0042401) | 3.32341690 |
| 97 | amine biosynthetic process (GO:0009309) | 3.32341690 |
| 98 | negative regulation of granulocyte differentiation (GO:0030853) | 3.30988109 |
| 99 | dendritic cell migration (GO:0036336) | 3.30274252 |
| 100 | NIK/NF-kappaB signaling (GO:0038061) | 3.30220819 |
| 101 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.28883804 |
| 102 | positive regulation of T-helper cell differentiation (GO:0045624) | 3.27603159 |
| 103 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.27365164 |
| 104 | cell killing (GO:0001906) | 3.26713769 |
| 105 | regulation of response to osmotic stress (GO:0047484) | 3.23602025 |
| 106 | * regulation of interleukin-4 production (GO:0032673) | 3.21569762 |
| 107 | response to bacterium (GO:0009617) | 3.20597608 |
| 108 | phagosome maturation (GO:0090382) | 3.20162437 |
| 109 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.19801866 |
| 110 | negative regulation of growth of symbiont in host (GO:0044130) | 3.18981983 |
| 111 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 3.18981983 |
| 112 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 3.18981983 |
| 113 | regulation of growth of symbiont in host (GO:0044126) | 3.18981983 |
| 114 | granulocyte chemotaxis (GO:0071621) | 3.18907523 |
| 115 | heme biosynthetic process (GO:0006783) | 3.18271404 |
| 116 | icosanoid biosynthetic process (GO:0046456) | 3.17992866 |
| 117 | fatty acid derivative biosynthetic process (GO:1901570) | 3.17992866 |
| 118 | detection of biotic stimulus (GO:0009595) | 3.17988069 |
| 119 | regulation of mast cell activation (GO:0033003) | 3.17068560 |
| 120 | tetrapyrrole biosynthetic process (GO:0033014) | 3.16994912 |
| 121 | adaptation of signaling pathway (GO:0023058) | 3.14409447 |
| 122 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.11183715 |
| 123 | * granulocyte migration (GO:0097530) | 3.10845874 |
| 124 | positive regulation of interleukin-8 production (GO:0032757) | 3.10813559 |
| 125 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.10074959 |
| 126 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.09445345 |
| 127 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.09445345 |
| 128 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.09445345 |
| 129 | modulation by symbiont of host immune response (GO:0052553) | 3.09445345 |
| 130 | positive regulation by symbiont of host defense response (GO:0052509) | 3.09445345 |
| 131 | modulation by symbiont of host defense response (GO:0052031) | 3.09445345 |
| 132 | * hydrogen peroxide catabolic process (GO:0042744) | 3.08498490 |
| 133 | positive regulation of granulocyte chemotaxis (GO:0071624) | 3.05153133 |
| 134 | response to muramyl dipeptide (GO:0032495) | 3.02769910 |
| 135 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.02282171 |
| 136 | response to host (GO:0075136) | 3.02282171 |
| 137 | response to host defenses (GO:0052200) | 3.02282171 |
| 138 | positive regulation of neutrophil chemotaxis (GO:0090023) | 3.01826373 |
| 139 | positive regulation of neutrophil migration (GO:1902624) | 3.01826373 |
| 140 | citrulline biosynthetic process (GO:0019240) | 3.00446285 |
| 141 | phospholipid homeostasis (GO:0055091) | 2.98185764 |
| 142 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.96305432 |
| 143 | detection of bacterium (GO:0016045) | 2.96142948 |
| 144 | regulation of T cell tolerance induction (GO:0002664) | 2.95384995 |
| 145 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.93849709 |
| 146 | regulation of granulocyte differentiation (GO:0030852) | 2.93457881 |
| 147 | regulation of macrophage cytokine production (GO:0010935) | 2.91941145 |
| 148 | myeloid leukocyte activation (GO:0002274) | 2.90855121 |
| 149 | positive regulation of regulated secretory pathway (GO:1903307) | 2.88139344 |
| 150 | porphyrin-containing compound metabolic process (GO:0006778) | 2.80687413 |
| 151 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.80301757 |
| 152 | activated T cell proliferation (GO:0050798) | 2.77337212 |
| 153 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.77296222 |
| 154 | regulation of gamma-delta T cell activation (GO:0046643) | 2.75058972 |
| 155 | regulation of B cell differentiation (GO:0045577) | 2.74542623 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 4.92515546 |
| 2 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.76322272 |
| 3 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.53138282 |
| 4 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.92901423 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.72221202 |
| 6 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.58745126 |
| 7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.30787679 |
| 8 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.26220267 |
| 9 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 3.18842381 |
| 10 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.05503950 |
| 11 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 3.02147568 |
| 12 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.93105619 |
| 13 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.89120326 |
| 14 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.75024259 |
| 15 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.69445218 |
| 16 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.66501924 |
| 17 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.65005740 |
| 18 | MYC_22102868_ChIP-Seq_BL_Human | 2.45192433 |
| 19 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.40147474 |
| 20 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.39350722 |
| 21 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.30249809 |
| 22 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.23837790 |
| 23 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.23483469 |
| 24 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.22331465 |
| 25 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.18007788 |
| 26 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.12494612 |
| 27 | UTX_26944678_Chip-Seq_JUKART_Human | 2.11177576 |
| 28 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 2.11021741 |
| 29 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.09096836 |
| 30 | MAF_26560356_Chip-Seq_TH1_Human | 2.08147711 |
| 31 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.07912812 |
| 32 | SPI1_23127762_ChIP-Seq_K562_Human | 1.99813768 |
| 33 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.95511844 |
| 34 | MYB_26560356_Chip-Seq_TH2_Human | 1.88863519 |
| 35 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.81834510 |
| 36 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.77218793 |
| 37 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.74084386 |
| 38 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.73231589 |
| 39 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.72156563 |
| 40 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.71937597 |
| 41 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.66652298 |
| 42 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.65072083 |
| 43 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.62173024 |
| 44 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.60472018 |
| 45 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.59146408 |
| 46 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.59018089 |
| 47 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.57761133 |
| 48 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.57074627 |
| 49 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.57002494 |
| 50 | MYB_26560356_Chip-Seq_TH1_Human | 1.54884986 |
| 51 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.54403156 |
| 52 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.52363771 |
| 53 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.43468092 |
| 54 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.42365630 |
| 55 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.41946414 |
| 56 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.40578871 |
| 57 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.39842178 |
| 58 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.35629004 |
| 59 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.34473258 |
| 60 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29607105 |
| 61 | GATA1_19941826_ChIP-Seq_K562_Human | 1.28777873 |
| 62 | MAF_26560356_Chip-Seq_TH2_Human | 1.28750084 |
| 63 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28617147 |
| 64 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.28063439 |
| 65 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.27385787 |
| 66 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.27360383 |
| 67 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.26925089 |
| 68 | GATA1_22025678_ChIP-Seq_K562_Human | 1.26579816 |
| 69 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.24731800 |
| 70 | GATA2_19941826_ChIP-Seq_K562_Human | 1.23892969 |
| 71 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.20411267 |
| 72 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.20366221 |
| 73 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.19040229 |
| 74 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.18773135 |
| 75 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18489781 |
| 76 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.18375397 |
| 77 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.14741798 |
| 78 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.14402002 |
| 79 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.13794572 |
| 80 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.12511648 |
| 81 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.12469670 |
| 82 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11191915 |
| 83 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.10319592 |
| 84 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.09818845 |
| 85 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.09734572 |
| 86 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.06058779 |
| 87 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.04525354 |
| 88 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.03318448 |
| 89 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.03103941 |
| 90 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.02682796 |
| 91 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 1.02147405 |
| 92 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.01775367 |
| 93 | GATA3_26560356_Chip-Seq_TH2_Human | 1.01294005 |
| 94 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.00358544 |
| 95 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00141026 |
| 96 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.97711793 |
| 97 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97550170 |
| 98 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95722979 |
| 99 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.95720371 |
| 100 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.95355839 |
| 101 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95351610 |
| 102 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.95134925 |
| 103 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.93158348 |
| 104 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.93082450 |
| 105 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.92451750 |
| 106 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.92272002 |
| 107 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.92034840 |
| 108 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.88886242 |
| 109 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.86322311 |
| 110 | P300_27268052_Chip-Seq_Bcells_Human | 0.85283058 |
| 111 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.84838465 |
| 112 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.84658846 |
| 113 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.83891667 |
| 114 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.83232377 |
| 115 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.82385289 |
| 116 | P68_20966046_ChIP-Seq_HELA_Human | 0.80474354 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 6.13456726 |
| 2 | MP0004147_increased_porphyrin_level | 4.27324786 |
| 3 | MP0003183_abnormal_peptide_metabolism | 4.10016712 |
| 4 | MP0003436_decreased_susceptibility_to | 3.99147882 |
| 5 | MP0000685_abnormal_immune_system | 3.58074042 |
| 6 | MP0009785_altered_susceptibility_to | 3.39401509 |
| 7 | MP0009278_abnormal_bone_marrow | 3.35332136 |
| 8 | MP0004510_myositis | 2.99937296 |
| 9 | MP0002419_abnormal_innate_immunity | 2.99395598 |
| 10 | MP0005058_abnormal_lysosome_morphology | 2.99170442 |
| 11 | MP0001835_abnormal_antigen_presentation | 2.80036600 |
| 12 | MP0002009_preneoplasia | 2.77170509 |
| 13 | MP0005025_abnormal_response_to | 2.71233432 |
| 14 | MP0005464_abnormal_platelet_physiology | 2.64927351 |
| 15 | MP0002405_respiratory_system_inflammati | 2.58728423 |
| 16 | MP0002877_abnormal_melanocyte_morpholog | 2.55155744 |
| 17 | MP0003300_gastrointestinal_ulcer | 2.48990095 |
| 18 | MP0001851_eye_inflammation | 2.30550878 |
| 19 | MP0005000_abnormal_immune_tolerance | 2.30078040 |
| 20 | MP0000343_altered_response_to | 2.23627089 |
| 21 | MP0001853_heart_inflammation | 2.22625807 |
| 22 | MP0001533_abnormal_skeleton_physiology | 2.16278498 |
| 23 | MP0003724_increased_susceptibility_to | 2.10461560 |
| 24 | MP0001545_abnormal_hematopoietic_system | 2.09817249 |
| 25 | MP0005397_hematopoietic_system_phenotyp | 2.09817249 |
| 26 | MP0001800_abnormal_humoral_immune | 2.01866099 |
| 27 | MP0002420_abnormal_adaptive_immunity | 1.95580833 |
| 28 | MP0001819_abnormal_immune_cell | 1.93737152 |
| 29 | MP0002452_abnormal_antigen_presenting | 1.92160949 |
| 30 | MP0001845_abnormal_inflammatory_respons | 1.92137524 |
| 31 | MP0000465_gastrointestinal_hemorrhage | 1.90703401 |
| 32 | MP0005645_abnormal_hypothalamus_physiol | 1.90292963 |
| 33 | MP0005387_immune_system_phenotype | 1.87853257 |
| 34 | MP0001790_abnormal_immune_system | 1.87853257 |
| 35 | MP0002148_abnormal_hypersensitivity_rea | 1.85217045 |
| 36 | MP0005310_abnormal_salivary_gland | 1.82656527 |
| 37 | MP0002723_abnormal_immune_serum | 1.82208216 |
| 38 | MP0005671_abnormal_response_to | 1.76573493 |
| 39 | MP0005083_abnormal_biliary_tract | 1.73356298 |
| 40 | MP0002876_abnormal_thyroid_physiology | 1.72410610 |
| 41 | MP0002735_abnormal_chemical_nociception | 1.69016987 |
| 42 | MP0002166_altered_tumor_susceptibility | 1.66590654 |
| 43 | * MP0002398_abnormal_bone_marrow | 1.65298690 |
| 44 | MP0002396_abnormal_hematopoietic_system | 1.64890028 |
| 45 | MP0009764_decreased_sensitivity_to | 1.59406722 |
| 46 | * MP0000716_abnormal_immune_system | 1.56755415 |
| 47 | MP0003172_abnormal_lysosome_physiology | 1.54004277 |
| 48 | MP0010155_abnormal_intestine_physiology | 1.51708257 |
| 49 | MP0004808_abnormal_hematopoietic_stem | 1.49288316 |
| 50 | MP0006082_CNS_inflammation | 1.49187365 |
| 51 | MP0008260_abnormal_autophagy | 1.47458405 |
| 52 | MP0003656_abnormal_erythrocyte_physiolo | 1.37715079 |
| 53 | MP0005409_darkened_coat_color | 1.37365201 |
| 54 | * MP0002429_abnormal_blood_cell | 1.34158656 |
| 55 | MP0008057_abnormal_DNA_replication | 1.32997101 |
| 56 | MP0008469_abnormal_protein_level | 1.31167696 |
| 57 | MP0004947_skin_inflammation | 1.25960789 |
| 58 | MP0004185_abnormal_adipocyte_glucose | 1.24945825 |
| 59 | MP0010352_gastrointestinal_tract_polyps | 1.23455309 |
| 60 | MP0003075_altered_response_to | 1.22615248 |
| 61 | MP0000015_abnormal_ear_pigmentation | 1.20121306 |
| 62 | MP0009333_abnormal_splenocyte_physiolog | 1.20102496 |
| 63 | MP0002722_abnormal_immune_system | 1.17682099 |
| 64 | MP0005076_abnormal_cell_differentiation | 1.16866241 |
| 65 | MP0002254_reproductive_system_inflammat | 1.16556471 |
| 66 | MP0003566_abnormal_cell_adhesion | 1.14848718 |
| 67 | MP0000858_altered_metastatic_potential | 1.12668627 |
| 68 | MP0003806_abnormal_nucleotide_metabolis | 1.11954634 |
| 69 | MP0000689_abnormal_spleen_morphology | 1.11672923 |
| 70 | MP0001986_abnormal_taste_sensitivity | 1.11383436 |
| 71 | MP0004883_abnormal_blood_vessel | 1.11158579 |
| 72 | MP0009840_abnormal_foam_cell | 1.08525734 |
| 73 | MP0010307_abnormal_tumor_latency | 1.06824209 |
| 74 | MP0001873_stomach_inflammation | 1.05840654 |
| 75 | MP0005075_abnormal_melanosome_morpholog | 1.02901234 |
| 76 | MP0001764_abnormal_homeostasis | 1.02635168 |
| 77 | MP0003448_altered_tumor_morphology | 0.98607399 |
| 78 | MP0009765_abnormal_xenobiotic_induced | 0.96614738 |
| 79 | MP0005451_abnormal_body_composition | 0.96220320 |
| 80 | MP0001663_abnormal_digestive_system | 0.96143632 |
| 81 | MP0003045_fibrosis | 0.96107374 |
| 82 | MP0005164_abnormal_response_to | 0.95649137 |
| 83 | MP0008874_decreased_physiological_sensi | 0.95427676 |
| 84 | MP0001348_abnormal_lacrimal_gland | 0.94394794 |
| 85 | MP0003221_abnormal_cardiomyocyte_apopto | 0.94091161 |
| 86 | MP0002006_tumorigenesis | 0.93431269 |
| 87 | MP0003828_pulmonary_edema | 0.92897399 |
| 88 | MP0002971_abnormal_brown_adipose | 0.92753992 |
| 89 | MP0002998_abnormal_bone_remodeling | 0.90516029 |
| 90 | MP0009115_abnormal_fat_cell | 0.90156494 |
| 91 | MP0003279_aneurysm | 0.88257047 |
| 92 | MP0003638_abnormal_response/metabolism_ | 0.87436121 |
| 93 | MP0004264_abnormal_extraembryonic_tissu | 0.87403576 |
| 94 | MP0002282_abnormal_trachea_morphology | 0.87272079 |
| 95 | MP0003111_abnormal_nucleus_morphology | 0.85630693 |
| 96 | MP0009931_abnormal_skin_appearance | 0.83081296 |
| 97 | MP0009763_increased_sensitivity_to | 0.81748380 |
| 98 | MP0002277_abnormal_respiratory_mucosa | 0.80513719 |
| 99 | MP0000703_abnormal_thymus_morphology | 0.80198354 |
| 100 | MP0005390_skeleton_phenotype | 0.79378811 |
| 101 | MP0005666_abnormal_adipose_tissue | 0.78826636 |
| 102 | MP0002837_dystrophic_cardiac_calcinosis | 0.78707442 |
| 103 | MP0002928_abnormal_bile_duct | 0.75749616 |
| 104 | MP0000604_amyloidosis | 0.75435866 |
| 105 | MP0002095_abnormal_skin_pigmentation | 0.74872519 |
| 106 | MP0003795_abnormal_bone_structure | 0.72129137 |
| 107 | MP0008995_early_reproductive_senescence | 0.71819545 |
| 108 | MP0000003_abnormal_adipose_tissue | 0.70006858 |
| 109 | MP0003453_abnormal_keratinocyte_physiol | 0.69654414 |
| 110 | MP0000920_abnormal_myelination | 0.69086258 |
| 111 | MP0002970_abnormal_white_adipose | 0.68477500 |
| 112 | MP0005621_abnormal_cell_physiology | 0.67596333 |
| 113 | MP0002019_abnormal_tumor_incidence | 0.67355637 |
| 114 | MP0003866_abnormal_defecation | 0.67140855 |
| 115 | MP0003959_abnormal_lean_body | 0.66929383 |
| 116 | MP0002933_joint_inflammation | 0.66804137 |
| 117 | MP0005023_abnormal_wound_healing | 0.65880236 |
| 118 | MP0000598_abnormal_liver_morphology | 0.65402292 |
| 119 | MP0000249_abnormal_blood_vessel | 0.64369390 |
| 120 | MP0003191_abnormal_cellular_cholesterol | 0.63569360 |
| 121 | MP0005167_abnormal_blood-brain_barrier | 0.61509736 |
| 122 | MP0008007_abnormal_cellular_replicative | 0.61037858 |
| 123 | MP0005174_abnormal_tail_pigmentation | 0.60591500 |
| 124 | MP0000609_abnormal_liver_physiology | 0.59121719 |
| 125 | MP0003693_abnormal_embryo_hatching | 0.58016063 |
| 126 | MP0006054_spinal_hemorrhage | 0.57700374 |
| 127 | MP0005381_digestive/alimentary_phenotyp | 0.56933567 |
| 128 | MP0001915_intracranial_hemorrhage | 0.56077508 |
| 129 | MP0003705_abnormal_hypodermis_morpholog | 0.55724980 |
| 130 | MP0003763_abnormal_thymus_physiology | 0.54685870 |
| 131 | MP0002132_abnormal_respiratory_system | 0.54643054 |
| 132 | MP0008961_abnormal_basal_metabolism | 0.54396474 |
| 133 | MP0005334_abnormal_fat_pad | 0.53315378 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 9.47034711 |
| 2 | Recurrent abscess formation (HP:0002722) | 8.60262677 |
| 3 | Recurrent gram-negative bacterial infections (HP:0005420) | 8.56265928 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 8.22768712 |
| 5 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 7.81667139 |
| 6 | Hypochromic microcytic anemia (HP:0004840) | 7.41676445 |
| 7 | Obstructive lung disease (HP:0006536) | 6.16680027 |
| 8 | Chronic obstructive pulmonary disease (HP:0006510) | 6.16680027 |
| 9 | Recurrent skin infections (HP:0001581) | 5.56841756 |
| 10 | Recurrent fungal infections (HP:0002841) | 5.48319013 |
| 11 | Abnormality of macrophages (HP:0004311) | 5.33648746 |
| 12 | Mediastinal lymphadenopathy (HP:0100721) | 5.31082005 |
| 13 | Cellulitis (HP:0100658) | 4.90913905 |
| 14 | Gingivitis (HP:0000230) | 4.87582800 |
| 15 | Hypochromic anemia (HP:0001931) | 4.50083685 |
| 16 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.43756667 |
| 17 | Recurrent cutaneous fungal infections (HP:0011370) | 4.32249738 |
| 18 | Chronic mucocutaneous candidiasis (HP:0002728) | 4.32249738 |
| 19 | Urticaria (HP:0001025) | 4.30630187 |
| 20 | Increased cerebral lipofuscin (HP:0011813) | 4.29436372 |
| 21 | Microcytic anemia (HP:0001935) | 3.96634296 |
| 22 | Meningitis (HP:0001287) | 3.91269119 |
| 23 | Stomatitis (HP:0010280) | 3.79506225 |
| 24 | Polycythemia (HP:0001901) | 3.78890907 |
| 25 | Increased IgE level (HP:0003212) | 3.73264506 |
| 26 | Recurrent pneumonia (HP:0006532) | 3.47323820 |
| 27 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.37588552 |
| 28 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.24697099 |
| 29 | Myositis (HP:0100614) | 3.24636345 |
| 30 | Paralysis (HP:0003470) | 3.21710607 |
| 31 | Petechiae (HP:0000967) | 3.15167435 |
| 32 | Abnormal hemoglobin (HP:0011902) | 3.14544443 |
| 33 | Cholelithiasis (HP:0001081) | 3.13921746 |
| 34 | Papilledema (HP:0001085) | 3.13900935 |
| 35 | Increased density of long bones (HP:0006392) | 3.10727449 |
| 36 | Periodontitis (HP:0000704) | 3.08483122 |
| 37 | Dysostosis multiplex (HP:0000943) | 3.03233814 |
| 38 | Interstitial pulmonary disease (HP:0006530) | 2.96017809 |
| 39 | Impaired platelet aggregation (HP:0003540) | 2.95598217 |
| 40 | Abnormal platelet function (HP:0011869) | 2.95598217 |
| 41 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.95137187 |
| 42 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.95137187 |
| 43 | Abnormality of glycolipid metabolism (HP:0010969) | 2.95137187 |
| 44 | Recurrent lower respiratory tract infections (HP:0002783) | 2.90775409 |
| 45 | Thrombocytosis (HP:0001894) | 2.90582587 |
| 46 | Abnormality of the fingertips (HP:0001211) | 2.87834066 |
| 47 | Vasculitis (HP:0002633) | 2.83807596 |
| 48 | Chest pain (HP:0100749) | 2.82464598 |
| 49 | Osteomyelitis (HP:0002754) | 2.82220007 |
| 50 | Gingival bleeding (HP:0000225) | 2.82160370 |
| 51 | Autoimmune thrombocytopenia (HP:0001973) | 2.81268595 |
| 52 | Recurrent viral infections (HP:0004429) | 2.80701174 |
| 53 | Abnormal platelet volume (HP:0011876) | 2.80328653 |
| 54 | Abnormal gallbladder morphology (HP:0012437) | 2.77183310 |
| 55 | Inflammation of the large intestine (HP:0002037) | 2.75607908 |
| 56 | Prolonged bleeding time (HP:0003010) | 2.73632682 |
| 57 | Spontaneous hematomas (HP:0007420) | 2.73356158 |
| 58 | Toxemia of pregnancy (HP:0100603) | 2.73179858 |
| 59 | Epistaxis (HP:0000421) | 2.69257405 |
| 60 | Sepsis (HP:0100806) | 2.68940946 |
| 61 | Gastrointestinal inflammation (HP:0004386) | 2.67056378 |
| 62 | Diaphragmatic weakness (HP:0009113) | 2.61472339 |
| 63 | Acute myeloid leukemia (HP:0004808) | 2.60502846 |
| 64 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.55073566 |
| 65 | Gastrointestinal stroma tumor (HP:0100723) | 2.53215324 |
| 66 | Acute lymphatic leukemia (HP:0006721) | 2.52892041 |
| 67 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.51982928 |
| 68 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.51982928 |
| 69 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.51982928 |
| 70 | Colitis (HP:0002583) | 2.49863441 |
| 71 | Annular pancreas (HP:0001734) | 2.47704385 |
| 72 | Thoracic kyphosis (HP:0002942) | 2.47571433 |
| 73 | Reticulocytosis (HP:0001923) | 2.45089211 |
| 74 | Upper motor neuron abnormality (HP:0002127) | 2.42482234 |
| 75 | Nonimmune hydrops fetalis (HP:0001790) | 2.41697242 |
| 76 | Vacuolated lymphocytes (HP:0001922) | 2.39715888 |
| 77 | Mucopolysacchariduria (HP:0008155) | 2.37635911 |
| 78 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.37635911 |
| 79 | Hepatosplenomegaly (HP:0001433) | 2.34508337 |
| 80 | Increased mean platelet volume (HP:0011877) | 2.33983441 |
| 81 | Leukocytosis (HP:0001974) | 2.31579223 |
| 82 | Pustule (HP:0200039) | 2.28503577 |
| 83 | Restrictive lung disease (HP:0002091) | 2.28031313 |
| 84 | Skin ulcer (HP:0200042) | 2.26199999 |
| 85 | Episodic fever (HP:0001954) | 2.23700413 |
| 86 | Abnormality of T cell physiology (HP:0011840) | 2.23039381 |
| 87 | Chronic otitis media (HP:0000389) | 2.22729155 |
| 88 | Hemoptysis (HP:0002105) | 2.20839439 |
| 89 | Purpura (HP:0000979) | 2.20314579 |
| 90 | IgM deficiency (HP:0002850) | 2.17539968 |
| 91 | Orchitis (HP:0100796) | 2.15695070 |
| 92 | Systemic lupus erythematosus (HP:0002725) | 2.15500831 |
| 93 | Cheilitis (HP:0100825) | 2.14804257 |
| 94 | Arterial thrombosis (HP:0004420) | 2.14387895 |
| 95 | Poikilocytosis (HP:0004447) | 2.14135256 |
| 96 | Verrucae (HP:0200043) | 2.13297182 |
| 97 | Papilloma (HP:0012740) | 2.13297182 |
| 98 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.13136167 |
| 99 | Peritonitis (HP:0002586) | 2.07290195 |
| 100 | Menorrhagia (HP:0000132) | 2.07132784 |
| 101 | Abnormality of the thoracic spine (HP:0100711) | 2.04784832 |
| 102 | Lymphopenia (HP:0001888) | 2.04556195 |
| 103 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 2.02502265 |
| 104 | Cutaneous photosensitivity (HP:0000992) | 1.99722350 |
| 105 | Agammaglobulinemia (HP:0004432) | 1.99379599 |
| 106 | Pulmonary embolism (HP:0002204) | 1.99234771 |
| 107 | Abnormality of the lumbar spine (HP:0100712) | 1.98993714 |
| 108 | Abnormality of the gallbladder (HP:0005264) | 1.98907046 |
| 109 | Acanthocytosis (HP:0001927) | 1.97411074 |
| 110 | Hematochezia (HP:0002573) | 1.96848021 |
| 111 | Hypermelanotic macule (HP:0001034) | 1.95511832 |
| 112 | Granulocytopenia (HP:0001913) | 1.94138840 |
| 113 | Prolonged neonatal jaundice (HP:0006579) | 1.93874971 |
| 114 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.92681198 |
| 115 | Slender build (HP:0001533) | 1.90823801 |
| 116 | Pallor (HP:0000980) | 1.90678403 |
| 117 | Abnormality of binocular vision (HP:0011514) | 1.89181549 |
| 118 | Diplopia (HP:0000651) | 1.89181549 |
| 119 | Eosinophilia (HP:0001880) | 1.87939199 |
| 120 | Pulmonary infiltrates (HP:0002113) | 1.87798865 |
| 121 | Paresthesia (HP:0003401) | 1.84916727 |
| 122 | Abnormality of reticulocytes (HP:0004312) | 1.84286808 |
| 123 | Amaurosis fugax (HP:0100576) | 1.83926994 |
| 124 | Encephalitis (HP:0002383) | 1.81177826 |
| 125 | Abnormality of B cell number (HP:0010975) | 1.80846653 |
| 126 | Hypergammaglobulinemia (HP:0010702) | 1.78508377 |
| 127 | Poikiloderma (HP:0001029) | 1.76756134 |
| 128 | Keratoconjunctivitis (HP:0001096) | 1.75968092 |
| 129 | Amyloidosis (HP:0011034) | 1.75145649 |
| 130 | Gastrointestinal infarctions (HP:0005244) | 1.71758213 |
| 131 | Thyroiditis (HP:0100646) | 1.70355251 |
| 132 | Pyloric stenosis (HP:0002021) | 1.67677296 |
| 133 | Emphysema (HP:0002097) | 1.65595003 |
| 134 | Joint hemorrhage (HP:0005261) | 1.65029974 |
| 135 | Panhypogammaglobulinemia (HP:0003139) | 1.64644116 |
| 136 | Abnormality of the prostate (HP:0008775) | 1.64200003 |
| 137 | Thrombophlebitis (HP:0004418) | 1.60737984 |
| 138 | Abnormality of iron homeostasis (HP:0011031) | 1.60292295 |
| 139 | Acrocyanosis (HP:0001063) | 1.59993855 |
| 140 | Increased serum ferritin (HP:0003281) | 1.59723539 |
| 141 | Abnormality of the common coagulation pathway (HP:0010990) | 1.59172849 |
| 142 | Abnormality of T cells (HP:0002843) | 1.56408136 |
| 143 | Recurrent sinusitis (HP:0011108) | 1.56163724 |
| 144 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.55444114 |
| 145 | Retrobulbar optic neuritis (HP:0100654) | 1.51393736 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRAK4 | 6.31524127 |
| 2 | PRPF4B | 3.81494832 |
| 3 | EPHB1 | 3.42353609 |
| 4 | RIPK4 | 3.16119054 |
| 5 | ERN1 | 2.73261166 |
| 6 | GRK6 | 2.64893284 |
| 7 | MAP3K14 | 2.52427886 |
| 8 | BLK | 2.49608878 |
| 9 | MAP4K1 | 2.47548726 |
| 10 | FES | 2.44309635 |
| 11 | IRAK3 | 2.43226166 |
| 12 | ALK | 2.33453059 |
| 13 | BTK | 2.21569309 |
| 14 | TRIB3 | 2.21449701 |
| 15 | CLK1 | 2.13130112 |
| 16 | EEF2K | 2.03819390 |
| 17 | PIK3CG | 1.98688569 |
| 18 | PRKG2 | 1.94701026 |
| 19 | STK10 | 1.92224649 |
| 20 | PTK6 | 1.91260451 |
| 21 | CSK | 1.91215801 |
| 22 | TTN | 1.87994768 |
| 23 | TYK2 | 1.70521612 |
| 24 | LRRK2 | 1.60311461 |
| 25 | HCK | 1.57202497 |
| 26 | MAP3K13 | 1.55455472 |
| 27 | TAOK2 | 1.55127539 |
| 28 | PKN2 | 1.49193060 |
| 29 | FGR | 1.47234678 |
| 30 | TBK1 | 1.42985086 |
| 31 | MAP3K3 | 1.41986434 |
| 32 | MAP3K12 | 1.41276912 |
| 33 | PAK4 | 1.28345835 |
| 34 | KSR2 | 1.28224341 |
| 35 | MAP2K3 | 1.27437313 |
| 36 | MAP3K6 | 1.27364735 |
| 37 | SYK | 1.27232584 |
| 38 | TESK2 | 1.26085882 |
| 39 | HIPK2 | 1.22811938 |
| 40 | MAPK4 | 1.17504080 |
| 41 | PIK3CA | 1.15802138 |
| 42 | IKBKE | 1.10519794 |
| 43 | ZAP70 | 1.08945783 |
| 44 | SIK2 | 1.05381403 |
| 45 | TESK1 | 0.99147011 |
| 46 | CAMK1G | 0.99084459 |
| 47 | TRPM7 | 0.98764889 |
| 48 | PIM1 | 0.98486699 |
| 49 | BMX | 0.98306624 |
| 50 | MAP3K11 | 0.96738700 |
| 51 | JAK2 | 0.96061837 |
| 52 | TAOK3 | 0.94167463 |
| 53 | TEC | 0.93773946 |
| 54 | ITK | 0.89770504 |
| 55 | IKBKB | 0.85971804 |
| 56 | RAF1 | 0.83748497 |
| 57 | LYN | 0.82596647 |
| 58 | KIT | 0.81524728 |
| 59 | PRKAA2 | 0.81144350 |
| 60 | MAP3K9 | 0.80941440 |
| 61 | RPS6KA4 | 0.80841799 |
| 62 | MAPK12 | 0.80621951 |
| 63 | PDPK1 | 0.78733157 |
| 64 | NEK2 | 0.78074203 |
| 65 | PDK1 | 0.74485902 |
| 66 | PTK2B | 0.70670818 |
| 67 | DAPK2 | 0.70359359 |
| 68 | CSF1R | 0.67994486 |
| 69 | JAK3 | 0.67711745 |
| 70 | MAP2K4 | 0.67597419 |
| 71 | BRD4 | 0.66393122 |
| 72 | MAP3K5 | 0.65456820 |
| 73 | PRKCD | 0.64550144 |
| 74 | LCK | 0.64467741 |
| 75 | MAP3K8 | 0.63742467 |
| 76 | MARK2 | 0.63394097 |
| 77 | EIF2AK1 | 0.62386973 |
| 78 | SIK3 | 0.62220053 |
| 79 | MAPK7 | 0.59958284 |
| 80 | MAPKAPK2 | 0.59640409 |
| 81 | JAK1 | 0.58246970 |
| 82 | RPS6KA2 | 0.58246309 |
| 83 | PIM2 | 0.56165769 |
| 84 | WNK1 | 0.56110868 |
| 85 | MARK3 | 0.55726959 |
| 86 | KDR | 0.54918882 |
| 87 | MATK | 0.53299378 |
| 88 | MAP3K7 | 0.52090872 |
| 89 | EGFR | 0.50599457 |
| 90 | CDK19 | 0.50299403 |
| 91 | RPS6KB2 | 0.49497444 |
| 92 | ILK | 0.49481907 |
| 93 | MAP3K10 | 0.47952007 |
| 94 | RET | 0.47456233 |
| 95 | CDK12 | 0.47336301 |
| 96 | TAOK1 | 0.46986283 |
| 97 | FYN | 0.46856298 |
| 98 | RPS6KA1 | 0.46167572 |
| 99 | DMPK | 0.45664162 |
| 100 | TGFBR2 | 0.45310216 |
| 101 | PTK2 | 0.44868804 |
| 102 | MAP2K1 | 0.44132021 |
| 103 | MAP2K2 | 0.43793714 |
| 104 | PLK4 | 0.42023590 |
| 105 | SGK3 | 0.41109845 |
| 106 | MAPK3 | 0.40469183 |
| 107 | FLT3 | 0.40361057 |
| 108 | STK11 | 0.38185832 |
| 109 | TXK | 0.37786641 |
| 110 | RPS6KL1 | 0.37636157 |
| 111 | RPS6KC1 | 0.37636157 |
| 112 | CHUK | 0.37016335 |
| 113 | RPS6KA6 | 0.35295917 |
| 114 | MAP3K1 | 0.34553766 |
| 115 | STK4 | 0.34494509 |
| 116 | LIMK1 | 0.34086170 |
| 117 | AKT1 | 0.33766325 |
| 118 | TNK2 | 0.33729694 |
| 119 | MOS | 0.33157883 |
| 120 | MTOR | 0.32567686 |
| 121 | MAPK11 | 0.30494942 |
| 122 | PRKACG | 0.29648120 |
| 123 | CDK6 | 0.28413640 |
| 124 | PRKCH | 0.28150450 |
| 125 | FGFR3 | 0.25919795 |
| 126 | CDK4 | 0.25860530 |
| 127 | SRC | 0.25324667 |
| 128 | STK24 | 0.24994017 |
| 129 | CAMK1D | 0.24742773 |
| 130 | PRKCQ | 0.24578781 |
| 131 | YES1 | 0.24189574 |
| 132 | BMPR2 | 0.23165258 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Asthma_Homo sapiens_hsa05310 | 6.52365354 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 4.38632659 |
| 3 | Other glycan degradation_Homo sapiens_hsa00511 | 3.45830237 |
| 4 | Osteoclast differentiation_Homo sapiens_hsa04380 | 3.03910214 |
| 5 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.84910181 |
| 6 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.76969428 |
| 7 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 2.37964402 |
| 8 | Tuberculosis_Homo sapiens_hsa05152 | 2.07226827 |
| 9 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.03558311 |
| 10 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 2.03288513 |
| 11 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.02734992 |
| 12 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.85279538 |
| 13 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.82138089 |
| 14 | Histidine metabolism_Homo sapiens_hsa00340 | 1.79718178 |
| 15 | Legionellosis_Homo sapiens_hsa05134 | 1.72204750 |
| 16 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.66531683 |
| 17 | Pertussis_Homo sapiens_hsa05133 | 1.65267892 |
| 18 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.54975873 |
| 19 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.54869821 |
| 20 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.54594938 |
| 21 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.53161939 |
| 22 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.51949945 |
| 23 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.51735921 |
| 24 | Shigellosis_Homo sapiens_hsa05131 | 1.50050178 |
| 25 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.48611195 |
| 26 | Platelet activation_Homo sapiens_hsa04611 | 1.41708872 |
| 27 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.41561834 |
| 28 | Phagosome_Homo sapiens_hsa04145 | 1.40357517 |
| 29 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.40021349 |
| 30 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.38704548 |
| 31 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.31576551 |
| 32 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.31024790 |
| 33 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.28120139 |
| 34 | Malaria_Homo sapiens_hsa05144 | 1.23638191 |
| 35 | Salmonella infection_Homo sapiens_hsa05132 | 1.21745911 |
| 36 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.21248261 |
| 37 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.20969029 |
| 38 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.19599176 |
| 39 | Hepatitis B_Homo sapiens_hsa05161 | 1.12849654 |
| 40 | Amoebiasis_Homo sapiens_hsa05146 | 1.06970368 |
| 41 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.03104096 |
| 42 | Apoptosis_Homo sapiens_hsa04210 | 1.02839357 |
| 43 | Measles_Homo sapiens_hsa05162 | 1.00052116 |
| 44 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.97527615 |
| 45 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.96977216 |
| 46 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.96712464 |
| 47 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.96565983 |
| 48 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.96124023 |
| 49 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.93271798 |
| 50 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.91885783 |
| 51 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.88406951 |
| 52 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.88402393 |
| 53 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.88367907 |
| 54 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.87180022 |
| 55 | Influenza A_Homo sapiens_hsa05164 | 0.85058420 |
| 56 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.83174486 |
| 57 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.76172296 |
| 58 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.75675143 |
| 59 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.75654419 |
| 60 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.74956051 |
| 61 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.72737761 |
| 62 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.69111931 |
| 63 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.68813301 |
| 64 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.68657776 |
| 65 | Insulin resistance_Homo sapiens_hsa04931 | 0.67689290 |
| 66 | Allograft rejection_Homo sapiens_hsa05330 | 0.65471426 |
| 67 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.64793548 |
| 68 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.64550150 |
| 69 | ABC transporters_Homo sapiens_hsa02010 | 0.62066491 |
| 70 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.61882153 |
| 71 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.61553124 |
| 72 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.60946950 |
| 73 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.60128818 |
| 74 | Hepatitis C_Homo sapiens_hsa05160 | 0.55340232 |
| 75 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.55235535 |
| 76 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.55098593 |
| 77 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.55047842 |
| 78 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.54694678 |
| 79 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.54689383 |
| 80 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.53964338 |
| 81 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.51727397 |
| 82 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.51165388 |
| 83 | Viral myocarditis_Homo sapiens_hsa05416 | 0.50395939 |
| 84 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.50219517 |
| 85 | HTLV-I infection_Homo sapiens_hsa05166 | 0.49436807 |
| 86 | Galactose metabolism_Homo sapiens_hsa00052 | 0.48865194 |
| 87 | Glioma_Homo sapiens_hsa05214 | 0.48190929 |
| 88 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.47689415 |
| 89 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.47023318 |
| 90 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.46829419 |
| 91 | Lysosome_Homo sapiens_hsa04142 | 0.45739902 |
| 92 | Prostate cancer_Homo sapiens_hsa05215 | 0.45591180 |
| 93 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.45555350 |
| 94 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.44944432 |
| 95 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.44568135 |
| 96 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.42013822 |
| 97 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.41940522 |
| 98 | Base excision repair_Homo sapiens_hsa03410 | 0.40588820 |
| 99 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.39162700 |
| 100 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.38719569 |
| 101 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.37651928 |
| 102 | Long-term potentiation_Homo sapiens_hsa04720 | 0.36754593 |
| 103 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.36640821 |
| 104 | Endocytosis_Homo sapiens_hsa04144 | 0.36606563 |
| 105 | Melanoma_Homo sapiens_hsa05218 | 0.34664285 |
| 106 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.34302293 |
| 107 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.34119681 |
| 108 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.33489998 |
| 109 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.33237532 |
| 110 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.33168798 |
| 111 | Pathways in cancer_Homo sapiens_hsa05200 | 0.32719258 |
| 112 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.32030593 |
| 113 | Colorectal cancer_Homo sapiens_hsa05210 | 0.30849006 |
| 114 | DNA replication_Homo sapiens_hsa03030 | 0.29955511 |
| 115 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.28153021 |
| 116 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.26704776 |
| 117 | Bladder cancer_Homo sapiens_hsa05219 | 0.26448056 |
| 118 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.26342569 |
| 119 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.25589622 |
| 120 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.24873817 |
| 121 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.23784933 |
| 122 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.23652036 |
| 123 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.23009072 |

